|Application:||Gene expression microarray analysis|
|Number of samples:||65|
|Release date:||Nov 2 2011|
|Last update date:||Oct 29 2018|
|Diseases:||Adenoma, Carcinoma, Adrenocortical Carcinoma|
|Dataset link||Beta-catenin status effects in human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)|
Human samples of 33 adrenocortical carcinomas, 22 adrenocortical adenomas, and 10 normal adrenal cortex samples, each from a different patient, had mRNA assays performed using Affymetrix HG_U133_plus_2 arrays, with 54675 probe-sets. 23 of the carcinomas were used in survival analysis. 27 additional samples without array data were also used in a survival analysis.